Lexpos News

The NHS Business Services Authority (NHSBSA) produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 55) contains some useful information and advice on: Prescription switching – reduce the chances of it happening to you NHS Prescription Prepayment Certificates (PPC) Medicines covered by the Hormone Replacement Therapy Prescription Prepayment Certificate [...]

The post NHSBSA ‘Hints & Tips’ – Issue 56 appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Co-trimoxazole 80mg/400mg per 5ml adult suspension (Aspen Pharma Trading Limited) Drug alert number: EL (24)A/32 Date issued: 25 July 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Co-trimoxazole 80mg/400mg per 5ml adult suspension (Aspen Pharma Trading Limited) Company name: Aspen [...]

The post MHRA Class 4 Medicines Defect Information: Co-trimoxazole 80mg/400mg per 5ml adult suspension (Aspen Pharma Trading Limited) appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (25/07/2024) announced the following list of price concessions for July 2024: Drug Pack size Price concession Agomelatine 25mg tablets 28 £13.50 Amisulpride 200mg tablets 60 £28.42 Betamethasone valerate 0.1% [...]

The post July 2024 Price Concessions 2nd Update appeared first on Community Pharmacy England.

Community pharmacy owners have just under a week left to complete the Community Pharmacy Assurance Framework (CPAF) screening questionnaire before the deadline of midnight on Wednesday 31st July 2024.   As a result of NHS regulations introduced at the end of 2020, completion of CPAF is now a requirement of the Terms of Service. Therefore, pharmacy owners [...]

The post Just under a week left to complete CPAF screening survey  appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 12 July 2024) has been published and includes articles on: Epimax Ointment and Epimax Paraffin-Free Ointment: reports of ocular surface toxicity and ocular chemical injury Letters and medicine recalls sent to healthcare professionals in June 2024. To see the latest [...]

The post MHRA Drug Safety Update: July 2024 appeared first on Community Pharmacy England.